Why TNF Inhibitors Still Matter in the Evolving Plaque Psoriasis Treatment Landscape
Tumor necrosis factor inhibitors continue to reshape the treatment landscape for plaque psoriasis, especially for patients with moderate to severe disease who need more than topical therapy. By targeting a key inflammatory driver, these biologics can deliver meaningful skin clearance, reduce symptom burden, and improve quality of life. Their relevance remains strong as clinicians and …
Why TNF Inhibitors Still Matter in the Evolving Plaque Psoriasis Treatment Landscape Read More »